Syndax Pharmaceutica
SNDX
Real-time BATS EXCHANGE - 04/26 05:40:21 pm
10.705USD
+3.56%
Prev.10.3900
Open10.4500
High10.7196
Low10.4500
Volume36 035
Last news
Financials
Sales 2018 2,01 M
EBIT 2018 -90,8 M
R. net 2018 -89,6 M
Tréso. 2018 183 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 34,9x
EV / Sales 2019 6,43x
Capitalization 253 M
Company
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies.Its products include candidate and entinostat.The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October...
Sector :
Biopharmaceuticals
Calendar :
2018-05-14 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance12,114,814,3
Spread/Res.-12%-28%-26%
Spread/Supp.3,9%37%33%
Support10,37,808,03